[Tickers Inside] 7 Solid Gainers Over the Last 5 Sessions

Stocks with 5 days of consecutive price advances. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message ["We need batteries. Literally everywhere."]( [Read about this company's once-in-a-lifetime graphite opportunity -- before Wall Street]( --------------------------------------------------------------- February 21, 2023 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers across all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- Sponsor Message [The Humble Mineral at the Heart of the EV Revolution (Not Lithium)]( may know of graphite as what's in the tip of a No. 2 pencil, but it is the key to many forms of renewable energy. Today, this humble mineral is at the epicenter of the electric car revolution. Because what most people don't know is today's EV batteries contain more than 220 pounds of graphite - more than lithium, copper or aluminum! [Get the Full Story On This New American Graphite Opportunity]( --------------------------------------------------------------- [Ambrx Biopharma, AMAM]( Recent Analyst Action: Joel Beatty, analyst at Robert W. Baird, reiterates coverage on [Ambrx Biopharma (AMAM)](in the Healthcare sector with a Buy rating and a price target of $4.00 (5 days ago). - Recent Price: $$4.74 - Average Analyst Price Target: $4.00 (-15.61%) - Market Cap: $$125.51M [TipRanks.com]( also reports that [Ambrx Biopharma](currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $4.00 . The target pricing ranges from a high forecast of $4.00 down to a low forecast of $4.00. [Ambrx Biopharma (AMAM)](’s last closing price was $$4.74 which would put the average price target at $$4.00. Here are 3rd party ratings for [AMAM](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: buy - Zacks.com: Hold, Top 37% (93 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [#1 Stock for Energy Crisis (Buy Now for Just $8)]( the world suffers an oil shock… And gas prices rip higher… One tiny company could have the answer to the global energy crisis. It’s using AI to crack open the largest untapped energy source on the planet… 5X larger than the biggest oil field on Earth. [Act fast, this $8 stock could be moments away from appreciating considerably.]( --------------------------------------------------------------- [Eos Energy Enterprises, EOSE]( Recent Analyst Action: Christopher Souther, analyst at B.Riley Financial, reiterates coverage on [Eos Energy Enterprises (EOSE)](in the Industrial Goods sector with a Buy rating and a price target of $3.00 (2 weeks ago). - Recent Price: $$1.975 - Average Analyst Price Target: $7.00 (254.43%) - Market Cap: $$161.05M [TipRanks.com]( also reports that [Eos Energy Enterprises](currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $7.00 . The target pricing ranges from a high forecast of $11.00 down to a low forecast of $3.00. [Eos Energy Enterprises (EOSE)](’s last closing price was $$1.975 which would put the average price target at $$7.00. Here are 3rd party ratings for [EOSE](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Top 36% (91 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- [DraftKings, DKNG]( Recent Analyst Action: Ryan Sigdahl, analyst at Craig-Hallum, reiterates coverage on [DraftKings (DKNG)](in the Services sector with a Buy rating and a price target of $27.00 (11 hours ago). - Recent Price: $$20.345 - Average Analyst Price Target: $22.45 (3.76%) - Market Cap: $$17.29B [TipRanks.com]( also reports that [DraftKings](currently has 20 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $22.45 . The target pricing ranges from a high forecast of $30.00 down to a low forecast of $15.00. [DraftKings (DKNG)](’s last closing price was $$20.345 which would put the average price target at $$21.11. Here are 3rd party ratings for [DKNG](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: buy - Zacks.com: Hold, Top 27% (69 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [The Dividend Stock to Leave for Your Grandchildren]( you tired of your so-called "safe" income stocks slashing dividends while the share prices fall? There is a better way. I just revealed my safest most reliable and [most consistent dividend stock]( - and it pays a sky high yield with dividends paid EVERY month. This company has also increased its monthly dividend twice a year every year for the past 8 years. [Tap here to reveal the name of this stock for free.]( --------------------------------------------------------------- [Xilio Therapeutics, XLO]( Recent Analyst Action: Michael Ulz, analyst at Morgan Stanley, reiterates coverage on [Xilio Therapeutics (XLO)](in the Healthcare sector with a Buy rating and a price target of $10.00 (3 weeks ago). - Recent Price: $$3.62 - Average Analyst Price Target: $9.75 (169.34%) - Market Cap: $$98.35M [TipRanks.com]( also reports that [Xilio Therapeutics](currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $9.75 . The target pricing ranges from a high forecast of $13.00 down to a low forecast of $7.00. [Xilio Therapeutics (XLO)](’s last closing price was $$3.62 which would put the average price target at $$9.75. Here are 3rd party ratings for [XLO](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 37% (93 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- [Encore Wire, WIRE]( Recent Analyst Action: Brent Thielman, analyst at D.A. Davidson, reiterates coverage on [Encore Wire (WIRE)](in the Industrial Goods sector with a Buy rating and a price target of $250.00 (5 days ago). - Recent Price: $$200.15 - Average Analyst Price Target: $250.00 (24.91%) - Market Cap: $$3.66B [TipRanks.com]( also reports that [Encore Wire](currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $250.00 . The target pricing ranges from a high forecast of $250.00 down to a low forecast of $250.00. [Encore Wire (WIRE)](’s last closing price was $$200.15 which would put the average price target at $$250.00. Here are 3rd party ratings for [WIRE](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Strong Buy, Top 1% (1 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message ["TAKE THAT, CHINA!" USA Gains in EV Battery Arms Race]( you know each electric car battery requires 220 pounds of graphite - more than lithium, copper, or aluminum? China enjoyed a "near monopoly" in this vital ingredient... until the U.S. made a blockbuster announcement. Now one little-known company is set to play a crucial role in the booming $7 trillion EV revolution. [Get the full story on this new North American graphite opportunity]( --------------------------------------------------------------- [Terns Pharmaceuticals, TERN]( Recent Analyst Action: Silvan Tuerkcan, analyst at JMP Securities, reiterates coverage on [Terns Pharmaceuticals (TERN)](in the Healthcare sector with a Buy rating and a price target of $17.00 (1 week ago). - Recent Price: $$10.78 - Average Analyst Price Target: $12.60 (32.19%) - Market Cap: $$508.42M [TipRanks.com]( also reports that [Terns Pharmaceuticals](currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $12.60 . The target pricing ranges from a high forecast of $19.00 down to a low forecast of $6.00. [Terns Pharmaceuticals (TERN)](’s last closing price was $$10.78 which would put the average price target at $$14.25. Here are 3rd party ratings for [TERN](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Buy, Top 37% (93 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- [Aldeyra Therapeutics, ALDX]( Recent Analyst Action: Thomas Shrader, analyst at BTIG, reiterates coverage on [Aldeyra Therapeutics (ALDX)](in the Healthcare sector with a Buy rating and a price target of $29.00 (2 weeks ago). - Recent Price: $$7.09 - Average Analyst Price Target: $22.33 (214.95%) - Market Cap: $$416.36M [TipRanks.com]( also reports that [Aldeyra Therapeutics](currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $22.33 . The target pricing ranges from a high forecast of $29.00 down to a low forecast of $15.00. [Aldeyra Therapeutics (ALDX)](’s last closing price was $$7.09 which would put the average price target at $$22.33. Here are 3rd party ratings for [ALDX](: - TipRanks.com: Strong Buy - TradingView.com: n/a (possibly response change) - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 41% (103 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [The Biggest "Missing Ingredient" in the $7 Trillion EV Market]( has owned the graphite market for decades. But the U.S. just added graphite to a list of super-critical minerals... "essential for America's National Defense." Perfect timing for a "made in America" graphite company looking to mine, manufacture, and recycle graphite for the booming electric car market. [Don't Miss Your Opportunity to Benefit from This Breaking News]( --------------------------------------------------------------- And there you have it--7 Five Day Gainers across all US Exchanges. Sincerely, Editor, MarketTickerPress.com Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software